Siga Technologiesincis An American Pharmaceutical Company Based In New York Cityfounded In 1995The Company Specializes In Developing Medicines Aimed At Preventing And Treating Emerging Infectious Diseases With Significant Unmet Medical Needssiga Is Publicly Traded On The Nasdaq Under The Ticker Symbol Siga And Is Part Of The Russell 2000 Index The Company Offers Health Security Servicesfocusing On Research And Development To Combat Infectious Diseasesits Flagship Producttecovirimatmarketed As Tpoxxis The First Fda Approved Treatment For Smallpox And Is Effective Against Other Orthopoxvirusesincluding Monkeypoxtpoxx Is Available In Both Oral And Intravenous Formulationswith Options For Post Exposure Prophylaxissiga Collaborates With U Sfederal Agenciesincluding The Strategic National Stockpile And The Department Of Defenseto Provide Countermeasures Against Serious Health Threatssiga S Strategy Emphasizes Strengthening Government Partnershipsadvancing Regulatory Approvalscultivating Strategic Collaborationsand Expanding Into New Therapeutic Areas To Enhance Global Health Security
